Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Limited benefits of thalidomide and dexamethasone maintenance after autologous stem cell transplantation in newly diagnosed multiple myeloma patients: a prospective phase II multi-center study in Korea.
Byun JM, Kim SA, Koh Y, Shin DY, Kwon JH, Kim JS, Kim K, Min CK, Eom HS, Lee JJ, Bang SM, Yoon SS. Byun JM, et al. Among authors: kim js, kim sa, kim k. Curr Probl Cancer. 2022 Feb;46(1):100786. doi: 10.1016/j.currproblcancer.2021.100786. Epub 2021 Aug 20. Curr Probl Cancer. 2022. PMID: 34481658 Free article. Clinical Trial.
Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers.
Kim SA, Park H, Kim KJ, Kim JW, Sung JH, Nam M, Lee JH, Jung EH, Suh KJ, Lee JY, Kim SH, Lee JO, Kim JW, Kim YJ, Kim JH, Bang SM, Lee JS, Lee KW. Kim SA, et al. Among authors: kim kj, kim yj, kim sh, kim jw, kim jh. J Cancer Res Clin Oncol. 2022 Nov;148(11):2995-3005. doi: 10.1007/s00432-021-03872-4. Epub 2021 Dec 1. J Cancer Res Clin Oncol. 2022. PMID: 34853888
Amphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancer.
Kim SA, Park H, Kim KJ, Kim JW, Sung JH, Nam M, Lee JH, Jung EH, Suh KJ, Lee JY, Kim SH, Lee JO, Kim JW, Kim YJ, Kim JH, Bang SM, Lee JS, Lee KW. Kim SA, et al. Among authors: kim kj, kim yj, kim sh, kim jw, kim jh. Sci Rep. 2021 Dec 10;11(1):23803. doi: 10.1038/s41598-021-03197-9. Sci Rep. 2021. PMID: 34893673 Free PMC article.
The effect of metformin or dipeptidyl peptidase 4 inhibitors on clinical outcomes in metastatic non-small cell lung cancer treated with immune checkpoint inhibitors.
Yang J, Kim SH, Jung EH, Kim SA, Suh KJ, Lee JY, Kim JW, Kim JW, Lee JO, Kim YJ, Lee KW, Kim JH, Bang SM, Lee JS. Yang J, et al. Among authors: kim yj, kim sh, kim jw, kim sa, kim jh. Thorac Cancer. 2023 Jan;14(1):52-60. doi: 10.1111/1759-7714.14711. Epub 2022 Nov 9. Thorac Cancer. 2023. PMID: 36351567 Free PMC article.
1,318 results